Nanobiotix Files Routine 6-K Disclosure
Ticker: NBTX · Form: 6-K · Filed: May 12, 2025 · CIK: 1760854
Sentiment: neutral
Topics: reporting, sec-filing, routine-disclosure
TL;DR
Nanobiotix files routine 6-K, no major news.
AI Summary
Nanobiotix S.A. filed a Form 6-K on May 12, 2025, to report its status as a foreign private issuer filing annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates but serves as a routine disclosure for international companies listed in the U.S.
Why It Matters
This filing is a standard procedural document for foreign companies, indicating Nanobiotix S.A. is adhering to its reporting obligations as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material information that would typically impact risk.
Key Players & Entities
- Nanobiotix S.A. (company) — Filer of the Form 6-K
- May 12, 2025 (date) — Filing date of the Form 6-K
- Form 20-F (document) — Annual report form for foreign private issuers
- Form 6-K (document) — Type of filing submitted
FAQ
What is the purpose of this Form 6-K filing by Nanobiotix S.A.?
The Form 6-K filed on May 12, 2025, serves as a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, indicating the company's reporting status.
Does Nanobiotix S.A. file its annual reports on Form 20-F or Form 40-F?
Nanobiotix S.A. indicates it files annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
The Form 6-K was filed on May 12, 2025.
Where is Nanobiotix S.A. located?
Nanobiotix S.A.'s principal executive office is located at 60 Rue de Wattignies, 75012 Paris, France.
Does this filing contain specific financial results or operational updates?
No, this Form 6-K appears to be a routine administrative filing and does not contain specific financial results or operational updates.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 12, 2025 regarding Nanobiotix S.A. (NBTX).